Voritic (voriconazole) Injection-Another Remarkable Achievement

Bio-Labs Launched Voritic (Voriconazole) IV Injection in its Hi-Tech Portfolio. It is used in treatment of Invasive Fungal Infections (IFI) like invasive aspergillosis, candidaemia, and fluconazole resistant candidiasis in patients who are undergoing transplants, leukemia’s and other critical care settings.
It’s the only true lyophilized formulation available in Pakistan


Launching of Colinext (Colistimethate Sodium) 1MIU

Bio-Labs recently developed Colinext (colistimethate) 1MIU in fulfilling the needs of emerging molecules in the market. It is used in the infections caused by gram negative bacteria’s which are highly resistant to conventional therapies.

The Trade Commissioner and The First Secretary Counsel of the Embassy of Italy visit the manufacturing facility of Bio-Labs

It was an honor to host Mr. Salvatore Parano, the Trade Commissioner, and Mr. Augusto Palmieri, the First Secretary Counsel of the Embassy of Italy, during their visit to the manufacturing facility of Bio-Labs in Islamabad.

They expressed their appreciation for the standards upheld by Bio-Labs in maintaining the quality of its products and commended the rapid growth in Bio-Labs’ exports. The meeting was filled with synergy and fruitful discussions. Our team’s professionalism and expertise were on full display, leaving a lasting impression on our esteemed guest.

The Trade Commissioner and First Secretary Counsel encouraged collaborative efforts for joint projects in pharmaceutical development and the production of food supplement products, emphasizing the potential for expansion in Italy.

Bio-Labs Launched Omezka (Omeprazole B.P) To Its Extensive Portfolio

Bio-Labs is thrilled to announce the launch of Omezka (Omeprazole B.P.) in our Pain and Gut Care Division. Omezka (Omeprazole B.P) is used to treat excess stomach acid in conditions such as non-cancerous stomach ulcers, gastroesophageal reflux disease (GERD), active duodenal ulcer, Zollinger-Ellison syndrome, and erosive esophagitis. Omeprazole works by blocking gastric acid production and is from a group of medicines called Proton Pump Inhibitors.

At Bio-Labs, we are dedicated to advancing healthcare through innovation. Omezka stands as a testament to our commitment to well-being!